According to Gram Research analysis, a plant extract from Dicliptera chinensis called polysaccharide (DCP) significantly reduced fatty liver disease in laboratory mice by reshaping gut bacteria and improving bile acid metabolism. The extract lowered blood sugar, reduced liver fat accumulation, and decreased cellular damage through a specific molecular pathway involving a microRNA called miR-3073b-5p. However, these findings come from animal studies only—human clinical trials are needed before this treatment can be recommended for people.
Researchers studied a plant called Dicliptera chinensis and found that a substance from it called polysaccharide (DCP) may help treat fatty liver disease caused by poor diet and metabolism problems. In experiments with mice and liver cells, DCP reduced fat buildup in the liver, lowered blood sugar and cholesterol, and reduced inflammation. The plant extract worked by changing the bacteria in the gut and improving how the body processes bile acids, which are digestive fluids. These findings suggest DCP could become a natural treatment option for people with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition affecting millions worldwide.
Key Statistics
A 2026 research article published in the International Journal of Biological Macromolecules found that Dicliptera chinensis polysaccharide (DCP) significantly reduced hepatic steatosis (fatty liver) and improved blood sugar control in mice with diet-induced metabolic dysfunction-associated steatotic liver disease.
The study demonstrated that DCP treatment restored normal bile acid metabolism and reshaped gut microbiota composition in mice with fatty liver disease, suggesting that changes in digestive bacteria and bile acids are key mechanisms of the plant extract’s protective effects.
Molecular analysis revealed that DCP reduced abnormally high levels of miR-3073b-5p microRNA in fatty liver disease, allowing a protective protein called CAMKK2 to function properly and activate cellular defense pathways.
The Quick Take
- What they studied: Whether a natural plant extract (polysaccharide from Dicliptera chinensis) could treat fatty liver disease caused by unhealthy diet and metabolic problems
- Who participated: Laboratory mice fed a high-sugar, high-fat diet to mimic fatty liver disease, plus liver cells grown in dishes. The study did not involve human participants.
- Key finding: The plant extract significantly reduced fat accumulation in the liver, lowered blood sugar and cholesterol levels, and reduced oxidative stress (cellular damage) in mice with diet-induced fatty liver disease
- What it means for you: This research suggests a natural plant-based treatment might help people with fatty liver disease, but human clinical trials are needed before it can be recommended as a therapy. Do not self-treat with this plant extract without medical guidance.
The Research Details
Scientists conducted laboratory experiments using two main approaches. First, they studied mice that developed fatty liver disease from eating a high-sugar, high-fat diet, then gave some mice the plant extract (DCP) to see if it helped. Second, they grew liver cells in dishes and exposed them to the same conditions, testing how the plant extract affected them at the cellular level.
The researchers used advanced molecular techniques to understand how the plant extract worked. They analyzed genetic material (RNA) to identify which genes were affected, used special tests to confirm direct interactions between molecules, and examined the bacteria living in the mice’s digestive systems. They also measured bile acids, which are important digestive chemicals produced by the liver.
This multi-layered approach allowed scientists to see the plant extract’s effects at different levels—from the whole animal down to individual cells and molecules—providing a more complete picture of how it might work.
Understanding the exact mechanism of how a natural treatment works is crucial for developing safe and effective therapies. By identifying the specific molecular pathways involved, researchers can determine whether this plant extract could be developed into a real medicine and which patients might benefit most. This type of detailed mechanistic research bridges the gap between traditional plant remedies and modern medicine.
This study used rigorous scientific methods including small RNA sequencing (advanced genetic analysis), dual-luciferase reporter assays (precise molecular testing), and 16S rRNA sequencing (detailed bacterial analysis). The research was published in a peer-reviewed journal specializing in biological molecules. However, the study was conducted entirely in laboratory and animal models—not in humans—so results may not directly translate to human patients. The sample size for animal experiments was not specified in the abstract, which limits assessment of statistical power.
What the Results Show
The plant extract (DCP) produced significant improvements in mice with diet-induced fatty liver disease. Specifically, it reduced high blood sugar levels (hyperglycemia), improved cholesterol and fat levels in the blood (dyslipidemia), decreased fat accumulation in liver tissue (hepatic steatosis), and reduced oxidative stress—cellular damage caused by harmful molecules called free radicals.
At the molecular level, the plant extract worked by reducing levels of a specific microRNA called miR-3073b-5p that was abnormally high in fatty liver disease. By lowering this microRNA, the extract allowed a protein called CAMKK2 to function properly. This activated a protective cellular pathway (AMPK/mTOR/Nrf2 signaling) that restored autophagy (the cell’s natural cleaning process) and prevented ferroptosis (a type of harmful cell death).
The research also revealed that the plant extract reshaped the composition of bacteria living in the mice’s digestive systems and restored normal bile acid metabolism. These changes in gut bacteria and bile acids appear to be key mechanisms through which the plant extract protected the liver.
The study demonstrated that the plant extract’s benefits extended beyond simple anti-inflammatory effects. The restoration of autophagy (cellular self-cleaning) and prevention of ferroptosis (a specific type of cell death) suggest the extract protects liver cells through multiple protective mechanisms. The reshaping of gut microbiota composition indicates that the plant extract’s benefits may depend on healthy gut bacteria, suggesting that gut health is important for treating fatty liver disease.
Previous research had shown that Dicliptera chinensis has anti-inflammatory and antioxidant properties, but the specific mechanism for treating fatty liver disease was unknown. This study builds on that foundation by identifying the exact molecular pathway (the miR-3073b-5p/CAMKK2 axis) and the role of gut bacteria and bile acids. The findings align with growing evidence that gut microbiota and bile acid metabolism play important roles in liver disease, supporting a broader scientific understanding of how the digestive system influences liver health.
This research has several important limitations. First, all experiments were conducted in laboratory settings (cell cultures) or in mice—not in humans. Animal studies often don’t translate directly to human medicine due to biological differences. Second, the abstract does not specify the number of mice used or provide detailed statistical analysis, making it difficult to assess how reliable the results are. Third, the study examined one specific plant extract; results may not apply to other plant-based treatments. Finally, the research does not address whether the extract is safe for long-term human use or what the appropriate dose would be for people.
The Bottom Line
Based on this laboratory and animal research, the plant extract (DCP) shows promise as a potential treatment for metabolic dysfunction-associated steatotic liver disease. However, confidence in this recommendation is LOW because human clinical trials have not yet been conducted. Do not use this plant extract to self-treat fatty liver disease. If you have fatty liver disease, work with your healthcare provider on proven treatments including weight loss, dietary changes, and exercise. Future human studies are needed before this extract can be recommended as a therapy.
This research is most relevant to: (1) people with metabolic dysfunction-associated steatotic liver disease or fatty liver disease who are interested in natural treatment options; (2) researchers studying plant-based medicines and liver disease; (3) pharmaceutical companies developing new treatments for fatty liver disease. This research should NOT be used by individuals to self-diagnose or self-treat liver conditions without medical supervision.
In the animal studies, the plant extract showed benefits within the timeframe of the experiment, but the abstract does not specify how long the treatment lasted. For humans, if this treatment were eventually approved, benefits would likely take weeks to months to become apparent, similar to other liver disease treatments. Realistic expectations would require human clinical trials to establish.
Frequently Asked Questions
Can I use Dicliptera chinensis to treat my fatty liver disease?
Not yet based on current evidence. While laboratory and animal studies show promise, human clinical trials have not been conducted. Talk to your doctor about proven treatments including weight loss, dietary changes, and exercise. Do not self-treat without medical supervision.
How does this plant extract help fatty liver disease?
The extract works by changing gut bacteria composition and improving bile acid metabolism, which reduces a harmful microRNA (miR-3073b-5p) in the liver. This allows protective cellular pathways to activate, reducing fat accumulation and cellular damage in liver cells.
What is metabolic dysfunction-associated steatotic liver disease?
MASLD is fatty liver disease caused by metabolic problems like obesity, high blood sugar, and high cholesterol—not from alcohol use. It develops when fat accumulates in liver cells, potentially causing inflammation and damage over time.
When will this plant extract be available as a treatment?
Unknown. The research is still in early stages (laboratory and animal studies). If promising human clinical trials are conducted and completed successfully, it could take 5-10 years or more before regulatory approval and availability as a therapy.
Are there proven treatments for fatty liver disease right now?
Yes. Weight loss of 5-10% of body weight, reducing sugar and saturated fat intake, increasing physical activity, and managing blood sugar and cholesterol are proven to improve fatty liver disease. Work with your healthcare provider on a personalized treatment plan.
Want to Apply This Research?
- Users could track liver health markers if they have fatty liver disease: record blood test results for liver enzymes (ALT, AST), triglycerides, and fasting glucose levels every 3 months. Also track dietary adherence (high-sugar and high-fat food intake) and weight changes weekly.
- While waiting for human clinical trials, users should focus on proven interventions: reduce intake of high-sugar and high-fat foods, increase physical activity to 150 minutes per week, and maintain a healthy weight. The app could help users log meals, track exercise, and monitor weight trends.
- Establish a baseline of current liver health markers through blood work with a healthcare provider. Then track changes in diet quality, exercise frequency, and weight monthly. Schedule follow-up blood work every 3-6 months to monitor liver enzyme levels and metabolic markers. Do not attempt to monitor this condition without professional medical guidance.
This article summarizes laboratory and animal research on a plant extract for fatty liver disease. These findings have not been tested in humans and should not be used for self-diagnosis or self-treatment. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious medical condition requiring professional medical evaluation and treatment. If you have fatty liver disease or suspect you may have it, consult with a qualified healthcare provider before making any changes to your treatment plan. Do not use herbal supplements or plant extracts to replace proven medical treatments without explicit approval from your doctor. The information in this article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.